GAIDANO, Valentina
 Distribuzione geografica
Continente #
EU - Europa 3.809
NA - Nord America 2.286
AS - Asia 984
AF - Africa 103
SA - Sud America 47
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 7
Totale 7.264
Nazione #
US - Stati Uniti d'America 2.229
DE - Germania 1.706
IT - Italia 549
FR - Francia 473
CN - Cina 315
IN - India 248
PL - Polonia 146
GB - Regno Unito 128
CZ - Repubblica Ceca 120
NL - Olanda 97
GR - Grecia 94
RU - Federazione Russa 78
JP - Giappone 69
ID - Indonesia 64
VN - Vietnam 61
KR - Corea 53
CA - Canada 47
SE - Svezia 47
CH - Svizzera 44
RO - Romania 44
UA - Ucraina 41
HK - Hong Kong 38
ES - Italia 37
FI - Finlandia 34
ZA - Sudafrica 26
HR - Croazia 23
BR - Brasile 22
NG - Nigeria 21
AT - Austria 19
IR - Iran 19
SG - Singapore 19
PT - Portogallo 17
AU - Australia 16
BE - Belgio 16
TW - Taiwan 16
TR - Turchia 15
BG - Bulgaria 14
CI - Costa d'Avorio 12
DZ - Algeria 12
IE - Irlanda 12
NZ - Nuova Zelanda 12
PK - Pakistan 12
PH - Filippine 11
CL - Cile 10
MK - Macedonia 10
MX - Messico 9
RS - Serbia 9
EG - Egitto 8
AR - Argentina 7
MY - Malesia 7
A1 - Anonimo 6
IL - Israele 6
MA - Marocco 6
SI - Slovenia 6
DK - Danimarca 5
EE - Estonia 5
GH - Ghana 5
HU - Ungheria 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
BF - Burkina Faso 4
CO - Colombia 4
MD - Moldavia 4
NO - Norvegia 4
TH - Thailandia 4
AZ - Azerbaigian 3
BD - Bangladesh 3
IQ - Iraq 3
IS - Islanda 3
LT - Lituania 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
JO - Giordania 2
KH - Cambogia 2
OM - Oman 2
TG - Togo 2
UG - Uganda 2
UY - Uruguay 2
BO - Bolivia 1
BY - Bielorussia 1
EU - Europa 1
GL - Groenlandia 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MT - Malta 1
MU - Mauritius 1
PE - Perù 1
QA - Qatar 1
RE - Reunion 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 7.264
Città #
Leawood 254
Falls Church 200
Nürnberg 192
New York 174
Fairfield 121
Ashburn 95
Houston 86
Santa Cruz 78
Seattle 70
Wilmington 56
Polska 55
Buffalo 53
Ann Arbor 51
Woodbridge 51
Cambridge 46
Jakarta 45
Shanghai 44
Dong Ket 40
Beijing 34
Torino 30
Milan 28
Wuhan 28
Jinan 27
Chicago 26
Helsinki 26
Hyderabad 26
Maikammer 26
Wenzhou 26
Tokyo 25
Warsaw 24
Seoul 22
Naaldwijk 21
Turin 21
Boardman 20
Frankfurt am Main 19
Los Angeles 18
Athens 17
Landshut 17
Rome 17
Bologna 16
Chennai 16
Fuzhou 15
San Diego 15
Singapore 15
Bengaluru 14
Columbus 14
Delhi 14
Johannesburg 14
Pisa 14
San Francisco 14
Chaoyang 13
Duncan 13
Gurgaon 13
Indore 13
Mountain View 13
Ottawa 13
Richmond 13
Taipei 13
Bucharest 12
Guangzhou 12
Moncalieri 12
San Jose 12
Las Vegas 11
Madrid 11
Parsippany 11
Toronto 11
Vienna 11
Bad Kreuznach 10
Central District 10
Lodz 10
Munich 10
Palermo 10
Zagreb 10
Bedford 9
Berlin 9
Naples 9
San Mateo 9
Sezze 9
Shenyang 9
Udine 9
University Park 9
Amsterdam 8
Clearwater 8
Hangzhou 8
Kumar 8
Serres 8
Stockholm 8
Suri 8
Tettnang 8
Central 7
Hanoi 7
Islamabad 7
Lake Forest 7
London 7
Muizenberg 7
Mysore 7
Zurich 7
Atlanta 6
Castelnuovo Bozzente 6
Council Bluffs 6
Totale 2.847
Nome #
Emerging therapies for acute myeloid leukaemia using hDHODH inhibitors able to restore in vitro and in vivo myeloid differentiation, file e27ce42e-e3ed-2581-e053-d805fe0acbaa 4.586
Emerging therapies for acute myeloid leukaemia using hDHODH inhibitors, file e27ce42e-e3f2-2581-e053-d805fe0acbaa 1.371
Improvement of in vivo pharmacokinetic profile of M433, a potent and innovative hDHODH inhibitor., file e27ce42f-3286-2581-e053-d805fe0acbaa 369
Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH, file e27ce428-c072-2581-e053-d805fe0acbaa 166
Design and application of a novel PNA probe for the detection at single cell level of JAK2V617F mutation in Myeloproliferative Neoplasms, file e27ce42a-484f-2581-e053-d805fe0acbaa 147
ERYTHROFERRONE EXPRESSION LEVELS IN MYELODYSPLATIC SYNDROMES SHOW CLINICAL RELEVANCE, file e27ce42b-ba54-2581-e053-d805fe0acbaa 146
The synergism between DHODH inhibitors and dipyridamole leads to metabolic lethality in acute myeloid leukemia, file e27ce432-269b-2581-e053-d805fe0acbaa 141
The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy, file e27ce429-fdab-2581-e053-d805fe0acbaa 131
Development of cellular and humoral response against WT1 protein vaccination in mice, file e27ce428-c9cf-2581-e053-d805fe0acbaa 126
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients, file e27ce434-8c3d-2581-e053-d805fe0acbaa 120
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia, file e27ce42f-2687-2581-e053-d805fe0acbaa 103
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study, file e27ce42f-cf82-2581-e053-d805fe0acbaa 99
PROCEEDINGS OF THE MERCK & ELSEVIER YOUNG CHEMISTSSYMPOSIUM, file e27ce42d-c4a1-2581-e053-d805fe0acbaa 79
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes, file e27ce42a-4f6b-2581-e053-d805fe0acbaa 64
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience, file e27ce432-19f0-2581-e053-d805fe0acbaa 57
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors, file e27ce432-03f2-2581-e053-d805fe0acbaa 50
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors, file e27ce433-402c-2581-e053-d805fe0acbaa 47
TFR2 AND EpoR EXPRESSION AT DIAGNOSIS AS POSSIBLE PREDICTORS OF ERYTHROPOIETIN TREATMENT RESPONSE IN MDS PATIENTS, file e27ce42a-238a-2581-e053-d805fe0acbaa 46
Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia, file e27ce434-529c-2581-e053-d805fe0acbaa 43
A differentiating and apoptotic therapy for acute myeloid leukaemia using potent human dihydroorotate dehydrogenase inhibitors., file e27ce42e-f84b-2581-e053-d805fe0acbaa 34
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase inhibitors, file e27ce42d-bf81-2581-e053-d805fe0acbaa 33
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety, file 33b0c0fc-4948-4f36-822a-38bf37292599 27
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients, file e6ae021b-25ef-48d5-91bc-e38acd892e13 27
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-fd74-2581-e053-d805fe0acbaa 20
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bb56-2581-e053-d805fe0acbaa 19
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors, file e27ce42d-ad8b-2581-e053-d805fe0acbaa 6
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase inhibitors, file e27ce42d-9ae6-2581-e053-d805fe0acbaa 5
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold: SAR of the Biphenyl Moiety, file e27ce432-bcf1-2581-e053-d805fe0acbaa 5
Prognostic significance of The Wilms’ Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia, file e27ce42e-178a-2581-e053-d805fe0acbaa 4
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42d-2659-2581-e053-d805fe0acbaa 3
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42d-2aec-2581-e053-d805fe0acbaa 3
DHODH inhibitors and leukemia: an emergent interest for new myeloid differentiation agents, file e27ce42d-4cce-2581-e053-d805fe0acbaa 3
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes, file e27ce42a-4f6c-2581-e053-d805fe0acbaa 2
Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors, file e27ce42c-f112-2581-e053-d805fe0acbaa 2
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation, file e27ce42c-bb7d-2581-e053-d805fe0acbaa 1
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation, file e27ce42c-bb7e-2581-e053-d805fe0acbaa 1
Apoptotic and differentiating therapy for AML using potent human dihydroorotate dehydrogenase inhibitor, file e27ce434-f61f-2581-e053-d805fe0acbaa 1
Totale 8.087
Categoria #
all - tutte 11.123
article - articoli 0
book - libri 0
conference - conferenze 8.464
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201975 0 0 0 0 0 0 0 0 0 0 44 31
2019/20201.190 20 24 13 28 13 15 272 139 96 183 191 196
2020/20212.429 152 133 169 182 172 191 248 240 211 214 329 188
2021/20222.483 210 185 196 217 199 141 163 173 184 200 435 180
2022/20231.455 134 211 231 183 151 103 72 98 84 89 72 27
2023/2024315 20 23 47 44 41 31 45 31 9 16 8 0
Totale 8.087